Postmenopausal Hormone Therapy and Cardiovascular Risk

Once thought to universally increase heart attack and stroke risk, hormone therapy (HT) is now recommended for women who meet certain criteria


Every day, about 6 million women in the United States begin the menopause transition. About 75% will experience hot flashes and night sweats, two vasomotor symptoms (VMS) that can seriously interfere with quality of life.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access